$ACUR
ACURA PHARMACEUTICALS, INC Stock $acur

$acur Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000114420415045799 Filed on August 03, 2015

Income Statement

Concept	2015 Q2	2014 Q4	2014 Q2
Revenue	$341.0K	$529.0K	$35.00K
YoY Change	874.29%	1411.43%	3400.0%
Cost Of Revenue	$100.0K	$40.00K	$40.00K
YoY Change	150.0%	0.0%
Gross Profit	$240.0K	$490.0K	-$10.00K
YoY Change	-2500.0%
Gross Profit Margin	70.38%	92.63%	-28.57%
Selling, General & Admin	$2.083M	$2.040M	$1.916M
YoY Change	8.72%	-26.88%	-2.99%
% of Gross Profit	867.92%	416.33%
Research & Development	$511.0K	$910.0K	$1.281M
YoY Change	-60.11%	13.75%	59.13%
% of Gross Profit	212.92%	185.71%
Depreciation & Amortization	$80.00K	$190.0K	$30.00K
YoY Change	166.67%	533.33%	-25.0%
% of Gross Profit	33.33%	38.78%
Operating Expenses	$2.594M	$2.984M	$3.307M
YoY Change	-21.56%	-15.13%	5.28%
Operating Profit	-$2.398M	-$2.455M	-$3.272M
YoY Change	-26.71%	-29.47%	4.2%
Interest Expense	$301.0K	-$240.0K	$302.0K
YoY Change	-0.33%	-500.0%
% of Operating Profit
Other Income/Expense, Net	-$265.0K	$0.00	-$249.0K
YoY Change	6.43%		-489.06%
Pretax Income	-$2.663M	-$2.700M	-$3.521M
YoY Change	-24.37%	-21.05%	14.47%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.663M	-$2.696M	-$3.521M
YoY Change	-24.37%	-21.1%	14.47%
Net Earnings / Revenue	-780.94%	-509.64%	-10060.0%
Basic Earnings Per Share	-$0.28	-$0.30	-$0.35
Diluted Earnings Per Share	-$0.28	-$0.30	-$0.35
COMMON SHARES
Basic Shares Outstanding	49.23M shares	48.85M shares	48.85M shares
Diluted Shares Outstanding	9.847M shares		48.85M shares

Balance Sheet

Concept	2015 Q2	2014 Q4	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.92M	$12.10M	$17.36M
YoY Change	-37.11%	-53.61%	-10.82%
Cash & Equivalents	$1.268M	$774.0K	$3.541M
Short-Term Investments	$9.651M	$11.32M	$13.82M
Other Short-Term Assets	$620.0K	$690.0K	$740.0K
YoY Change	-16.22%	-15.85%	39.62%
Inventory	$217.0K	$304.0K	$445.0K
Prepaid Expenses
Receivables	$110.0K	$80.00K	$90.00K
Other Receivables	$50.00K	$60.00K	$100.0K
Total Short-Term Assets	$11.92M	$13.23M	$18.73M
YoY Change	-36.35%	-51.8%	-8.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.121M	$957.0K	$928.0K
YoY Change	20.8%	1.7%	-7.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$180.0K	$0.00	$200.0K
YoY Change	-10.0%	-100.0%	1900.0%
Total Long-Term Assets	$3.038M	$2.802M	$3.127M
YoY Change	-2.85%	138.06%	208.38%
TOTAL ASSETS
Total Short-Term Assets	$11.92M	$13.23M	$18.73M
Total Long-Term Assets	$3.038M	$2.802M	$3.127M
Total Assets	$14.96M	$16.03M	$21.86M
YoY Change	-31.56%	-44.0%	1.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$261.0K	$217.0K	$114.0K
YoY Change	128.95%	-20.8%	-65.24%
Accrued Expenses	$863.0K	$568.0K	$1.444M
YoY Change	-40.24%	4.99%	113.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.419M	$1.758M	$477.0K
YoY Change	407.13%
Total Short-Term Liabilities	$3.852M	$2.992M	$2.379M
YoY Change	61.92%	170.28%	121.1%
LONG-TERM LIABILITIES
Long-Term Debt	$6.629M	$7.799M	$9.180M
YoY Change	-27.79%	-18.76%
Other Long-Term Liabilities	$290.0K	$190.0K
YoY Change
Total Long-Term Liabilities	$6.629M	$7.799M	$9.180M
YoY Change	-27.79%	-18.76%	91700.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.852M	$2.992M	$2.379M
Total Long-Term Liabilities	$6.629M	$7.799M	$9.180M
Total Liabilities	$10.77M	$10.98M	$11.56M
YoY Change	-6.82%	2.56%	969.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$363.7M	-$362.3M	-$356.7M
YoY Change	1.97%	3.78%	4.15%
Common Stock	$367.9M	$367.4M	$367.0M
YoY Change	0.27%	0.1%	1.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.190M	$5.052M	$10.30M
YoY Change
Total Liabilities & Shareholders Equity	$14.96M	$16.03M	$21.86M
YoY Change	-31.56%	-44.0%	1.65%

Cashflow Statement

Concept	2015 Q2	2014 Q4	2014 Q2
OPERATING ACTIVITIES
Net Income	-$2.663M	-$2.696M	-$3.521M
YoY Change	-24.37%	-21.1%	14.47%
Depreciation, Depletion And Amortization	$80.00K	$190.0K	$30.00K
YoY Change	166.67%	533.33%	-25.0%
Cash From Operating Activities	-$2.670M	-$2.350M	-$3.070M
YoY Change	-13.03%	-25.63%	-24.75%
INVESTING ACTIVITIES
Capital Expenditures	-$210.0K	-$30.00K	-$2.020M
YoY Change	-89.6%		10000.0%
Acquisitions
YoY Change
Other Investing Activities	$680.0K	$1.910M	-$240.0K
YoY Change	-383.33%	-39.94%	-124.74%
Cash From Investing Activities	$470.0K	$1.880M	-$2.260M
YoY Change	-120.8%	-40.88%	-337.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-360.0K	0.000	0.000
YoY Change		-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-2.670M	-2.350M	-3.070M
Cash From Investing Activities	470.0K	1.880M	-2.260M
Cash From Financing Activities	-360.0K	0.000	0.000
Net Change In Cash	-2.560M	-470.0K	-5.330M
YoY Change	-51.97%	-104.8%	85.07%
FREE CASH FLOW
Cash From Operating Activities	-$2.670M	-$2.350M	-$3.070M
Capital Expenditures	-$210.0K	-$30.00K	-$2.020M
Free Cash Flow	-$2.460M	-$2.320M	-$1.050M
YoY Change	134.29%	-26.58%	-74.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
CY2014Q4	acur	Inventory Reserve For Raw Materials InventoryReserveForRawMaterials	0	USD
CY2014Q4	acur	Inventory Reserve For Finished Goods InventoryReserveForFinishedGoods	0	USD
CY2014	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	13000	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4882000	shares
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5934000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4882000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5934000	shares
CY2014	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	51500000	USD
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	151400000	USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2015Q2	acur	Inventory Reserve For Finished Goods InventoryReserveForFinishedGoods	47000	USD
CY2014	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	2900000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	14000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	1352000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2226000	USD
CY2015Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	53000	USD
CY2014Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	66000	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	623000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	471000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	3000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	218000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	11924000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	13231000	USD
	acur	Proceeds From Market Offering Of Shares ProceedsFromMarketOfferingOfShares	225000	USD
	acur	Proceeds From Market Offering Of Shares ProceedsFromMarketOfferingOfShares	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	8000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	573000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2014Q1	acur	Inventory Reserve For Finished Goods InventoryReserveForFinishedGoods	133000	USD
CY2014Q2	acur	Inventory Reserve For Finished Goods InventoryReserveForFinishedGoods	68000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1121000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	220000	USD
CY2015Q1	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	314000	USD
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	255000	USD
CY2015Q1	acur	Inventory Reserve For Raw Materials InventoryReserveForRawMaterials	260000	USD
CY2015Q1	acur	Percentage Of Inventory Allowance Reserve PercentageOfInventoryAllowanceReserve	1	pure
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	957000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1742000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1845000	USD
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10000000	USD
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10000000	USD
CY2015Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0835	pure
CY2015Q2	acur	Debt Default Long Term Debt Percentage DebtDefaultLongTermDebtPercentage	0.1335	pure
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	260000	USD
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2018-12-01
	acur	Additions To Debt Instrument Unamortized Discount AdditionsToDebtInstrumentUnamortizedDiscount	33000	USD
CY2015Q1	acur	Debt Instrument Cash Maintenance DebtInstrumentCashMaintenance	2500000	USD
CY2015Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	5000000	USD
CY2015Q2	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	50000	USD
	acur	Debt Consulting Placement Fee DebtConsultingPlacementFee	100000	USD
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	231000	USD
CY2015Q2	us-gaap	Assets Assets	14962000	USD
CY2014Q4	us-gaap	Assets Assets	16033000	USD
CY2015Q2	us-gaap	Other Assets OtherAssets	175000	USD
CY2014Q4	us-gaap	Other Assets OtherAssets	0	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	261000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	217000	USD
CY2015Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	49000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	26000	USD
CY2015Q2	us-gaap	Interest Payable Current InterestPayableCurrent	65000	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	70000	USD
CY2015Q2	acur	Sales Returns Liability Current SalesReturnsLiabilityCurrent	195000	USD
CY2014Q4	acur	Sales Returns Liability Current SalesReturnsLiabilityCurrent	0	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	353000	USD
	acur	Agreement Termination Notice Description AgreementTerminationNoticeDescription	Egalet may terminate the Egalet Agreement for convenience on 120 days prior written notice, which termination may not occur prior to the second anniversary of Egalets launch of Oxaydo. Egalet also may terminate the Agreement prior to the launch of Oxaydo on 30 days prior written notice upon the occurrence of serious safety issues, regulatory restrictions and intellectual property issues, in each case involving Oxaydo
CY2015Q2	us-gaap	Marketable Securities MarketableSecurities	9651000	USD
CY2014Q4	us-gaap	Marketable Securities MarketableSecurities	11322000	USD
CY2015Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	109000	USD
CY2015Q2	acur	Restricted Stock Units Sale Price RestrictedStockUnitsSalePrice	0.01
CY2015Q2	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	49000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	13000000	USD
CY2015Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2419000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1758000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3852000	USD
CY2015Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	298000	shares
CY2014Q4	acur	Debt Instrument Issuance Costs DebtInstrumentIssuanceCosts	-162000	USD
	acur	Additions To Debt Instrument Issuance Costs AdditionsToDebtInstrumentIssuanceCosts	0	USD
	acur	Amortization Expense Of Debt Instrument Issuance Costs AmortizationExpenseOfDebtInstrumentIssuanceCosts	34000	USD
CY2015Q2	acur	Debt Instrument Issuance Costs DebtInstrumentIssuanceCosts	-128000	USD
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	9048000	USD
CY2015Q2	us-gaap	Sale Leaseback Transaction Transaction Costs Financing Activities SaleLeasebackTransactionTransactionCostsFinancingActivities	8000	USD
CY2015Q2	us-gaap	Sale Leaseback Transaction Net Proceeds Financing Activities SaleLeasebackTransactionNetProceedsFinancingActivities	220000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2992000	USD
CY2015Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6629000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7799000	USD
CY2015Q2	acur	Longterm Portion Of Accrued Interest LongtermPortionOfAccruedInterest	291000	USD
CY2014Q4	acur	Longterm Portion Of Accrued Interest LongtermPortionOfAccruedInterest	190000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	10772000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	10981000	USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	492000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	488000	USD
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	367456000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	366898000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-363745000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-362321000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14962000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16033000	USD
	us-gaap	Licenses Revenue LicensesRevenue	250000	USD
CY2015Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.1016	pure
CY2015Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.504
	acur	Issuance Of Common Stock Value Under Market Offerings IssuanceOfCommonStockValueUnderMarketOfferings	217000	USD
	acur	Proceeds From Issuance Of Common Stock Value Under Market Offerings ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings	8000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	112000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	201000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	233000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	342000	USD
CY2015Q2	acur	Share Based Compensation Expense Recognized In Operations ShareBasedCompensationExpenseRecognizedInOperations	151000	USD
CY2014Q2	acur	Share Based Compensation Expense Recognized In Operations ShareBasedCompensationExpenseRecognizedInOperations	257000	USD
	acur	Share Based Compensation Expense Recognized In Operations ShareBasedCompensationExpenseRecognizedInOperations	311000	USD
	acur	Share Based Compensation Expense Recognized In Operations ShareBasedCompensationExpenseRecognizedInOperations	455000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2014Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	76000	USD
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48848000	shares
CY2015Q2	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
CY2014Q2	us-gaap	Royalty Revenue RoyaltyRevenue	1000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	91000	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	34000	USD
CY2015Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	250000	USD
CY2014Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	0	USD
CY2015Q2	us-gaap	Revenues Revenues	341000	USD
CY2014Q2	us-gaap	Revenues Revenues	35000	USD
CY2015Q2	acur	Cost Of Sales Excluding Inventory Write Down CostOfSalesExcludingInventoryWriteDown	98000	USD
CY2014Q2	acur	Cost Of Sales Excluding Inventory Write Down CostOfSalesExcludingInventoryWriteDown	42000	USD
CY2015Q2	us-gaap	Inventory Write Down InventoryWriteDown	47000	USD
CY2014Q2	us-gaap	Inventory Write Down InventoryWriteDown	68000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	511000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1281000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2083000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1916000	USD
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	2739000	USD
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	3307000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2398000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3272000	USD
CY2015Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	36000	USD
CY2014Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	53000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	301000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	302000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2663000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3521000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-2663000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-3521000	USD
CY2015Q2	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-31000	USD
CY2014Q2	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	21000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2694000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3500000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-265000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-249000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49101000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48846000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49101000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48846000	shares
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000	USD
CY2012Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	260000	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	314000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	255000	USD
CY2015Q2	acur	Sales Returns Liability SalesReturnsLiability	195000	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	258000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	155000	USD
CY2015Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	251000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	281000	USD
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49217000	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49217000	shares
	dei	Entity Registrant Name EntityRegistrantName	ACURA PHARMACEUTICALS, INC
	us-gaap	Interest Expense InterestExpense	603000	USD
	dei	Trading Symbol TradingSymbol	ACUR
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	59006817	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Central Index Key EntityCentralIndexKey	0000786947
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3541000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8799000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	774000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12340000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49233000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48848000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49233000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48848000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-1424000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	311000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	33000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	4190000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	59000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58000	USD
	acur	Provision To Reduce Inventory To Net Realizable Value ProvisionToReduceInventoryToNetRealizableValue	307000	USD
	acur	Provision To Reduce Inventory To Net Realizable Value ProvisionToReduceInventoryToNetRealizableValue	201000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	311000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	455000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	97000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	93000	USD
	acur	Amortization Of Bond Premium In Marketable Securities AmortizationOfBondPremiumInMarketableSecurities	76000	USD
	acur	Amortization Of Bond Premium In Marketable Securities AmortizationOfBondPremiumInMarketableSecurities	138000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	103000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-108000	USD
	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-13000	USD
	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-18000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	220000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	394000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	152000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-83000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-215000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	7000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	175000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	44000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-160000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	295000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	902000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-353000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	20000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	23000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	32000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-503000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6053000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	96000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	1000	USD
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	1000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	529000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-355000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-520000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	494000	USD
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48848000	shares
CY2015Q2	acur	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	0	USD
CY2014Q4	acur	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	0	USD
CY2015Q2	acur	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	0	USD
CY2014Q4	acur	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	0	USD
	us-gaap	Interest Paid InterestPaid	348000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	acur	Provision For Sales Returns ProvisionForSalesReturns	195000	USD
	acur	Provision For Sales Returns ProvisionForSalesReturns	0	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	3000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	3500000	USD
CY2015Q2	acur	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	1700000	USD
CY2014Q4	acur	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	2800000	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	11300000	USD
CY2015Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	9700000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	11300000	USD
CY2014	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
CY2014	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	0	USD
CY2015Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	126000	USD
CY2014Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	260000	USD
CY2015Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	264000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44000	USD
CY2015Q2	us-gaap	Inventory Gross InventoryGross	390000	USD
CY2014Q4	us-gaap	Inventory Gross InventoryGross	304000	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	217000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	304000	USD
CY2015Q2	acur	Inventory Reserve For Raw Materials InventoryReserveForRawMaterials	126000	USD
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	165000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	94000	USD
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	436000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	253000	USD
CY2015Q2	acur	Other Accrued Taxes Current OtherAccruedTaxesCurrent	19000	USD
CY2014Q4	acur	Other Accrued Taxes Current OtherAccruedTaxesCurrent	13000	USD
CY2015Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	15000	USD
CY2014Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	15000	USD
CY2015Q2	acur	Accrued Other Professional Fees Current AccruedOtherProfessionalFeesCurrent	24000	USD
CY2014Q4	acur	Accrued Other Professional Fees Current AccruedOtherProfessionalFeesCurrent	83000	USD
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	54000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	49000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	863000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	568000	USD
CY2015Q2	acur	Marketing And Promotion MarketingAndPromotion	150000	USD
CY2014Q4	acur	Marketing And Promotion MarketingAndPromotion	61000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	63000	USD
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	9700000	USD
	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	0	USD
	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
CY2015Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	251000	USD
CY2015Q2	acur	Interest Expense Debt Discount InterestExpenseDebtDiscount	33000	USD
CY2014Q2	acur	Interest Expense Debt Discount InterestExpenseDebtDiscount	30000	USD
CY2015Q2	us-gaap	Debt Issuance Costs DebtIssuanceCosts	17000	USD
CY2014Q2	us-gaap	Debt Issuance Costs DebtIssuanceCosts	17000	USD
CY2014Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	255000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	512000	USD
	acur	Interest Expense Debt Discount InterestExpenseDebtDiscount	63000	USD
	us-gaap	Debt Issuance Costs DebtIssuanceCosts	34000	USD
	us-gaap	Interest Expense InterestExpense	609000	USD
	us-gaap	Debt Issuance Costs DebtIssuanceCosts	34000	USD
	acur	Interest Expense Debt Discount InterestExpenseDebtDiscount	59000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1185000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2741000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2979000	USD
CY2015Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9427000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	4000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	448000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	73000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	5250000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	0	USD
	us-gaap	Revenues Revenues	5698000	USD
	us-gaap	Revenues Revenues	77000	USD
	acur	Cost Of Sales Excluding Inventory Write Down CostOfSalesExcludingInventoryWriteDown	422000	USD
	acur	Cost Of Sales Excluding Inventory Write Down CostOfSalesExcludingInventoryWriteDown	80000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	307000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	201000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1475000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2719000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4380000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4175000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6584000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	7175000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-886000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7098000	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	71000	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	97000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-538000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-511000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1424000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7609000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	0	USD
	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	50000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	50000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1424000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7559000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2015Q2	acur	Debt Instrument Issuance Cost DebtInstrumentIssuanceCost	128000	USD
CY2014Q4	acur	Debt Instrument Issuance Cost DebtInstrumentIssuanceCost	162000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-20000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1540000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1595000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1361000	USD
	us-gaap	Product Warranty Accrual Additions From Business Acquisition ProductWarrantyAccrualAdditionsFromBusinessAcquisition	0	USD
	us-gaap	Product Warranty Accrual Additions From Business Acquisition ProductWarrantyAccrualAdditionsFromBusinessAcquisition	2000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	257000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	49163000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	48848000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	49055000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	48846000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	70000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	46000	shares

Files In Submission

Name	View Source	Status
0001144204-15-045799-index-headers.html	Edgar Link	pending
0001144204-15-045799-index.html	Edgar Link	pending
0001144204-15-045799.txt	Edgar Link	pending
0001144204-15-045799-xbrl.zip	Edgar Link	pending
acur-20150630.xml	Edgar Link	completed
acur-20150630.xsd	Edgar Link	pending
acur-20150630_cal.xml	Edgar Link	unprocessable
acur-20150630_def.xml	Edgar Link	unprocessable
acur-20150630_lab.xml	Edgar Link	unprocessable
acur-20150630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v415831_10q.htm	Edgar Link	pending
v415831_ex10-1.htm	Edgar Link	pending
v415831_ex31-1.htm	Edgar Link	pending
v415831_ex31-2.htm	Edgar Link	pending
v415831_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACUR
ACURA PHARMACEUTICALS, INC Stock $acur

2015 Q2 Form 10-Q Financial Statement

#000114420415045799 Filed on August 03, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACUR ACURA PHARMACEUTICALS, INC Stock $acur

2015 Q2 Form 10-Q Financial Statement

#000114420415045799 Filed on August 03, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACUR
ACURA PHARMACEUTICALS, INC Stock $acur